What mattered more than the headline miss was what the numbers revealed about the underlying business: electrolyzer revenue surged 46% sequentially, but the company's gross losses actually narrowed. That's the real story here. The GenEco electrolyzer segment delivered the quarter's bright spot. Revenue hit $65M, up 46% from Q2 2025, with over 230 MW of electrolyzers now mobilized globally. This is exactly what management has been banking on to drive future profitability. The segment's sequential growth suggests real commercial traction in hydrogen production equipment.